United States securities and exchange commission logo





                             July 31, 2023

       Kimball Carr
       Chief Executive Officer
       Inspire Veterinary Partners, Inc.
       780 Lynnhaven Parkway
       Suite 400
       Virginia Beach, VA 23452

                                                        Re: Inspire Veterinary
Partners, Inc.
                                                            Amendment No. 4 to
Registration Statement on Form S-1
                                                            Filed July 17, 2023
                                                            File No. 333-271198

       Dear Kimball Carr:

             We have reviewed your amended registration statement and have the
following
       comments. In some of our comments, we may ask you to provide us with
information so we
       may better understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.
Unless we note
       otherwise, our references to prior comments are to comments in our July
6, 2023 letter.

       Amendment No. 4 to Form S-1

       Risk Factors
       Our board of directors may designate. . ., page 23

   1.                                                   We refer to your
revised statement that you anticipate Mr. Keiser will own 48.5% of the
                                                        voting power and an
economic interest in approximately 34.7% of your outstanding
                                                        common stock
immediately following the closing of the offering. We also note your
                                                        revised statement that
Mr. Keiser and certain other directors and affiliate will control a
                                                        combined 39.3% of the
voting power and an economic interest in approximately 28.9% of
                                                        your outstanding common
stock. Please revise, as this information does not appear to be
                                                        consistent, and does
not appear to be consistent with the information in the beneficial
 Kimball Carr
Inspire Veterinary Partners, Inc.
July 31, 2023
Page 2
         ownership table.
Use of Proceeds, page 32

2.       In your response to comment 7 in your letter dated April 25, 2023, you
indicated that there
         were no current planned or probable acquisitions of additional
veterinary hospitals that
         required further consideration pursuant to Rule 8-04 of Regulation
S-X. We note that the
         free writing prospectus filed on July 27, 2023, indicates there are
three new locations
         under LOI, which will bring in an additional $6 million of annual
revenue, which
         compares to your revenue for the year ended December 31, 2022 of $9.8
million. Please
         tell us what consideration you gave to the requirements of Rule 8-04
of Regulation S-X
         with regard to these three new locations.
3.       We note that you have filed a free writing prospectus on July 27, 2023
indicating that you
         have entered into letters of intent for three new locations. Please
revise to identify the
         businesses and the status of your negotiations with respect to these
acquisitions. Refer to
         Item 504 of Regulation S-K.
Security Ownership of Certain Beneficial Owners and Management, page 76

4.       We acknowledge your revised disclosures. Please also revise the
narrative lead-in to the
         table to explain the number of shares outstanding that you are using,
with respect to each
         of the following scenarios: before the offerings, after the primary
offering, and after the
         secondary offering.
General

5.     We note that your amended and restated bylaws that you have filed
includes an exclusive
       forum provision. Please revise your prospectus to clearly and
prominently describe this
       provision, including the forum for litigation. In addition, please add a
risk factor to
       describe the risks of such a provision, including that there may be
increased costs for
       stockholders to bring a claim and that the provision can discourage or
limit investors'
       ability to bring a claim in a judicial forum that they find favorable.
Please also disclose
       whether this provision applies to actions arising under the Securities
Act or Exchange
       Act. If this provision does not apply to actions arising under the
Securities Act or
       Exchange Act, please also ensure that the exclusive forum provision in
the governing
FirstName LastNameKimball Carr
       documents states this clearly, or tell us how you will inform investors
in future filings that
Comapany     NameInspire
       the provision  doesVeterinary   Partners,
                            not apply to         Inc. arising under the
Securities Act or Exchange
                                         any actions
July 31,Act.
         2023 Page 2
FirstName LastName
 Kimball Carr
FirstName  LastNameKimball     Carr
Inspire Veterinary Partners, Inc.
Comapany
July       NameInspire Veterinary Partners, Inc.
     31, 2023
July 31,
Page  3 2023 Page 3
FirstName LastName
       You may contact Nudrat Salik at 202-551-3692 or Terence O'Brien at
202-551-3355 if
you have questions regarding comments on the financial statements and related
matters. Please
contact Jordan Nimitz at 202-551-5831 or Dorrie Yale at 202-551-8776 with any
other questions.



                                                          Sincerely,

                                                          Division of
Corporation Finance
                                                          Office of Industrial
Applications and
                                                          Services
cc:      Joe Laxague, Esq.